Skip to main content

UNC Lineberger researchers published in mSystems

October 8, 2018

UNC Lineberger’s Dirk Dittmer, PhD, Joel Parker, PhD, Sara Selitsky, PhD, and colleagues published a new study in the journal mSystems, an open access journal of the American Society for Microbiology. The study used data from The Cancer Genome Atlas project to explore whether Epstein-Barr virus is linked with additional cancer types beyond gastric cancer, nasopharyngeal carcinoma, and certain lymphomas, which have been convincingly linked to infection with the virus.

Insights about prostate cancer resistance could lead to treatment strategies

October 5, 2018

In the journal Molecular Cell, researchers led by UNC Lineberger’s G. Greg Wang, PhD, and H. Shelton Earp, MD, describe the role of a protein variant called androgen receptor variant 7 (AR-V7), which is an alternative form of the androgen receptor that plays a key role in prostate cancer development and treatment.

Metastatic breast cancer patients report high level of financial impact

October 5, 2018

A study led by UNC Lineberger’s Stephanie Wheeler, PhD, investigated the extent and severity of negative financial effects of cancer among women with breast cancer that has spread in the body. The preliminary results were presented at the American Society of Clinical Oncology’s Quality Care Symposium, held Sept. 28-29 in Phoenix.

Susan G. Komen awards UNC Lineberger $1.1M for breast cancer research

October 3, 2018

Included in the new investments by Susan G. Komen was $400,000 for UNC Lineberger’s Lisa Carey, MD, the physician-in-chief of the N.C. Cancer Hospital, Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, chief of the UNC School of Medicine Division of Hematology/Oncology, and a member of the Komen Scientific Advisory Board, for a study of HER2-positive breast cancer.

UNC researchers awarded emerging challenges grants

October 2, 2018

UNC School of Medicine, UNC Medical Center, and NC TraCS Institute awarded $50,000 to two teams of researchers led by UNC Lineberger’s Jill Bates, PharmD, clinical oncology precision medicine pharmacist, along with Alison Stuebe, MD, and Ana Whitney, MS, to study pharmacogenomics and social determinants of maternal health.

Lund leads PCORI-funded project to improve hybrid study designs

October 2, 2018

UNC Lineberger’s Jennifer Lund, PhD, assistant professor of epidemiology at UNC Gillings School of Global Public Health, recently was awarded a $732,000 grant from the Patient-Centered Outcomes Research Institute (PCORI). Lund serves as principal investigator for the project, “Enhancing hybrid study designs for comparative effectiveness research.”